|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07H 21/04 | |
| A61K 39/39 | |||
| A61P 11/00 | |||
| A61P 17/02 | |||
| A61P 31/00 | |||
| A61P 35/00 | |||
| A61P 37/00 | |||
| A61P 43/00 | |||
| C12N 15/00 | |||
| A61K 39/00 | |||
| C12N 15/117 |
| (11) | Patento numeris | 2873674 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13816791.1 |
| Europos patento paraiškos padavimo data | 2013-07-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-05-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2013/069107 |
| Data | 2013-07-12 |
| (87) | Numeris | WO 2014/010718 |
| Data | 2014-01-16 |
| (30) | Numeris | Data | Šalis |
| 201261671654 P | 2012-07-13 | US |
| (72) |
GEMBA, Takefumi, JP
|
| (73) |
Shin Nippon Biomedical Laboratories, Ltd.,
2438, Miyanoura-cho Kagoshima-shi, Kagoshima 891-1394,
JP
WaVe Life Sciences Japan, Inc., 2438, Miyanoura-cho Kagoshima-shi, Kagoshima 891-1394, JP |
| (54) | CHIRAL NUCLEIC ACID ADJUVANT |
| CHIRAL NUCLEIC ACID ADJUVANT |